SCHEMBL887329

SCHEMBL887329

OP1(=S)Oc2ccccc2-c2ccccc2O1

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
HSP90AA1 P07900 1/20 0.33
GPR84 Q9NQS5 1/20 0.32
PKM P14618 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL852188 0.90 ABCG2 (0.35) GPR84
SCHEMBL930972 0.79 KDM4E (0.31) KDM4EMAPK1ATM
Ammonia Solution, Strong SCHEMBL932033 0.77
SCHEMBL14901026 0.76 KDM4E (0.34) KDM4EMAPK1ATMHSP90AA1PKM
SCHEMBL30426151 0.76 GPR84 (0.52) KDM4EMAPK1ATMHSP90AA1GPR84
SCHEMBL887277 0.76 GPR84 (0.52) KDM4EMAPK1ATMHSP90AA1GPR84
SCHEMBL28581470 0.76 BCHE (0.32)
Guanidine SCHEMBL10324850 0.72
SCHEMBL10324737 0.72 ALDH1A1 (0.34) KDM4EMAPK1ATM
SCHEMBL11336478 0.71 KDM4E (0.31) KDM4EMAPK1ATMHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902207-B2 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-03-08 US disclosed
US-7902207-B2 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-03-08 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142639-A1 Process for production of amines SMS, CCNT1, PEAK1 KDM4E 1975/4885MAPK1 349/4885ATM 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.